InvestorsHub Logo
Followers 131
Posts 11471
Boards Moderated 0
Alias Born 01/06/2010

Re: None

Friday, 09/19/2014 7:47:09 AM

Friday, September 19, 2014 7:47:09 AM

Post# of 402699
The End of the Superbug!

Cellceutix may have one of the world’s best technologies for combating antibiotic resistant bacteria in its novel class of antibiotics called defensin mimetics. They are modeled after host defense proteins, the front line of defense in the innate human immune system. The drug destroys bacteria just like the body would naturally by penetrating the bacterial cell wall, rather than via a biochemical approach like most classes of antibiotics do today. This unique mechanism of action reduces the likelihood of bacterial resistance developing to almost nil.




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News